AJ R.
CEO
General Genomics
General Genomics develops AI/ML-powered bioinformatics solutions for government and commercial clients. The company provides data-driven tools, including synthetic data generation via SYN46™, to enhance analytics and streamline complex data workflows. Their services focus on delivering tailored informatics and data governance for sectors like public health, pharmaceuticals, and national security.
- Artificial Intelligence
- Data & Analytics
- Digital Health
- Government Technology
- Healthcare Technology
- Software Only
Updated 7 months ago
Funding
Raised to date
$900KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Organizations face challenges in leveraging complex biological and man-made systems data to predict health risks and optimize operational efficiency. Traditional methods often struggle to extract actionable insights from unstructured data, hindering proactive health management and resource allocation.
Solution
General Genomics provides AI/ML-driven solutions, including the Curo46™ platform, that analyze biological and man-made systems to enhance predictive health risk management and operational efficiency. The platform transforms unstructured data into structured, actionable insights, enabling proactive identification of health issues and optimization of resource allocation. By leveraging proprietary data sets and large language models, General Genomics delivers tailored AI products that improve outcomes for both military and commercial clients, enhancing force preservation, organizational efficiency, and overall operational delivery.
Target Audience
The primary customers are government agencies (federal, state, and local) and commercial entities in sectors such as healthcare, pharmaceuticals, insurance, sports medicine, and national security.
Features
- Curo46™: A machine learning platform analyzing biological and man-made systems.
- Proprietary data lake with over 600 million records for advanced AI-driven predictive analytics.
- AI/ML algorithms for comprehensive biosurveillance and biosecurity.
- Epidemiological modeling and simulation to forecast the spread of infectious diseases.
- AI/ML-driven supply chain risk management to predict potential disruptions.
- AI-enhanced workflow optimization training for streamlined processes and task automation.
- SYN46™: Synthetic data generation for secure and scalable data solutions.